Loading
Latest filing published 25 Apr 2022 for Tryp Therapeutics Inc..
No signal scores available.
David L Tousley is a declared insider of Tryp Therapeutics Inc., with filings sourced from SEDI. We count 2 filings; the first trade dates from 18 February 2022 and the latest from 22 April 2022.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 25 April 2022 came the latest disclosure, a transaction in Tryp Therapeutics Inc. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations